CUE

Cue Biopharma (CUE)

About Cue Biopharma (CUE)

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Details

Daily high

$33.03

Daily low

$25.41

Price at open

$27.72

52 Week High

$41.42

52 Week Low

$4.97

Market cap

119.5M

Dividend yield

0.00%

Volume

121,072

Avg. volume

80,324

P/E ratio

-5.15

Cue Biopharma News